LIPID METABOLISM finls

LIPID METABOLISM OVERVIEW

Lipid metabolism encompasses the biochemical processes involved in the synthesis and degradation of lipids in cells. It is crucial for storing energy, building cellular structures, and signaling. Key players in lipid metabolism include dietary fats, lipoproteins, apolipoproteins, and enzymes, which cooperate to facilitate lipid processing and transport in the body.

OBJECTIVES

  • Identify the Players of Lipid Metabolism: Understanding the entities involved in lipid processing.

  • Determine the Step-by-Step Process of Lipid Metabolism: Learning the sequence of events from digestion to absorption and transport.

  • Importance of Acetyl CoA: Recognizing Acetyl CoA's central role in lipid metabolism.

KEY PLAYERS IN LIPID METABOLISM

  1. Dietary Fats:

    • Triglycerides (TAG): The body's main energy storage form, stored in adipose tissue, and critical for lipid transport, packaged in lipoproteins.

    • Cholesterol: Vital for cell membrane structure, hormone production, and bile acid synthesis. It is synthesized in the liver.

  2. Phospholipids:

    • Fundamental in forming cell membranes, they separate cellular interiors from external environments and play roles in signaling and transport.

  3. Lipoproteins:

    • HDL (High-Density Lipoproteins): Transport cholesterol from tissues to the liver (ApoE, ApoC2).

    • LDL (Low-Density Lipoproteins): Transport cholesterol from the liver to peripheral tissues (ApoB100).

    • VLDL (Very Low-Density Lipoproteins): Produced in the liver to transport TAG (ApoB100, ApoE).

    • Chylomicrons: The largest lipoproteins, formed after the consumption of fats.

  4. Apolipoproteins:

    • ApoB48: Facilitates chylomicron secretion from the intestines.

    • ApoC2: Activates lipoprotein lipase to hydrolyze TAG into fatty acids.

    • ApoE: Helps recycle lipoprotein remnants to the liver.

    • ApoA1: Converts nascent HDL into mature HDL.

  5. Enzymes:

    • Pancreatic Lipase: Breaks down triglycerides into monoglycerides and fatty acids.

    • Cholesterol Esterase: Hydrolyzes cholesterol esters.

    • Phospholipase A2: Removes fatty acids from phospholipids.

CONTROL MECHANISMS

Cholecystokinin (CCK)

  • Source: Released from the jejunum in response to lipids and proteins.

  • Actions: Stimulates gallbladder contraction and enzyme release from pancreatic cells, decreases gastric motility.

Secretin

  • Source: Released when chyme enters the small intestine.

  • Actions: Stimulates pancreas and liver to release bicarbonate, enhancing pH for enzymes.

LIPID METABOLISM PROCESS

Overview

Lipid metabolism involves the breakdown of fats into smaller units, beginning with digestion and absorption in the intestines. It consists of both exogenous (dietary) and endogenous (internal) pathways for lipid processing.

Exogenous Pathway: Digestion

  • Initial Digestion: Begins with lingual lipase in the mouth and gastric lipase in the stomach.

  • Small Intestine: Lipids emulsified by bile salts from the liver, facilitated by CCK.

  • Enzymatic Breakdown: Pancreatic enzymes convert triglycerides into micelles.

Exogenous Pathway: Absorption

  • Micelle Formation: Lipids and monoglycerides are delivered to enterocytes.

  • Enterocyte Processing: Lipids are re-esterified into triglycerides and packaged into chylomicrons.

Exogenous Pathway: Transport

  • Chylomicron Release: Enter lymphatic system via the ApoB48.

  • Lipid Utilization: Enzymatic action from ApoC2 activates lipoprotein lipase to release free fatty acids for use or storage.

Endogenous Pathway: Triglyceride Metabolism

  • VLDL Formation: Liver packages triglycerides into VLDL, utilizing ApoC2 for lipase activation.

  • IDL and LDL Pathways: IDL can convert to LDL, mediating cholesterol transport.

Cholesterol Metabolism

  • Transportation: Cholesterol is transported back to the liver by HDL, completing the cycle.

  • Atherogenesis: Oxidative processes can lead LDL to form foam cells in atherosclerosis.

LIPID MALABSORPTION: STEATORRHEA

  • Symptoms: Increased fat in stool, characterized as bulky and oily.

  • Causes: Pancreatic insufficiency impacts digestion and absorption of lipids.

ACETYL CoA: CENTRAL TO LIPID METABOLISM

Acetyl CoA is a pivotal metabolite, comprised of an acetyl group and coenzyme A, essential for various metabolic pathways, including synthesis of triglycerides, phospholipids, and ketone bodies. Its production involves fatty acids, carbohydrates, and proteins.

KETONE BODIES

Synthesis and Usage

Ketone bodies are formed from Acetyl CoA in the liver during fasting states, serving as an alternative energy source, particularly for the brain. Their levels can indicate metabolic states such as diabetes or starvation. Normal blood ketone levels are less than 3 mg/dL.

Regulation

  • Production is influenced by the availability of Acetyl CoA, particularly during periods of high fatty acid mobilization from adipose tissue.

CHOLESTEROL SYNTHESIS

Regulation

Cholesterol synthesis must be meticulously controlled to prevent accumulation which can lead to cardiovascular issues. HMG-CoA reductase is the primary regulatory enzyme in this pathway.

Fate of Cholesterol

Cholesterol can be excreted in various forms: as bile acids, converted into neutral sterols by gut bacteria, or used for steroid hormone synthesis. Normal blood cholesterol levels should range between 150–200 mg/dL, with increased risk noted above 200 mg/dL.